The client is a pharmaceutical company giant with a major focus on development and manufacture of IP-led niche finished dosage formulations. They were facing challenges in managing paper-based stock and issuance logbooks, leading to manual errors, compliance risks, and inefficiencies. These outdated systems lacked real-time data recording and posed challenges during FDA audits. They partnered with us to digitalize the existing workflows & revamp MLT to comply with regulations.